RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Pictet Alternative Advisors
P

Pictet Alternative Advisors portfolio

Pictet Alternative Advisors has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Kinaset Therapeutics's $103M Series B+ round in January 2026, alongside Willett Advisors LLC, Vivo Capital, Sixty Degree Capital and 6 others. By category, its portfolio leans toward Health and bio (3) and AI agents (1). It has co-invested with Schroders Capital, RA Capital Management and Willett Advisors LLC, most often Schroders Capital (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 1.
Capital in their rounds: $523M.
Latest deal: Kinaset Therapeutics · Jan 9, 2026.

What Pictet Alternative Advisors invests in

Pictet Alternative Advisors recent investments

How Pictet Alternative Advisors invests

StageDealsCapital in rounds
Series B+ 3 100%$523M
YearDealsCapital in rounds
2023 1 33%$270M
2025 1 33%$150M
2026 1 33%$103M

Share is of the 3 rounds on Recent Funding that name Pictet Alternative Advisors. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Pictet Alternative Advisors portfolio companies

CompanyRound with Pictet Alternative AdvisorsTotal raisedLatest raise
KKinaset Therapeutics
Health and bio
Series B+ · $103M$143MJan 9, 2026
Series B+
AAzafaros
AI agents
Series B+ · $150M$177MMay 13, 2025
Series B+
GGenerate Biomedicines
Health and bio
Series B+ · $270M$640MSep 14, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Pictet Alternative Advisors, which is a subset of its real portfolio. API: /api/v1/investors/pictet-alternative-advisors (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy